BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17971996)

  • 1. Benzimidazole- and benzothiazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Colucci MA; Hassani M; Beall HD; Moody CJ
    Org Biomol Chem; 2007 Nov; 5(22):3665-73. PubMed ID: 17971996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolequinone antitumor agents: correlation between quinone structure, rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase, and in vitro cytotoxicity.
    Beall HD; Winski S; Swann E; Hudnott AR; Cotterill AS; O'Sullivan N; Green SJ; Bien R; Siegel D; Ross D; Moody CJ
    J Med Chem; 1998 Nov; 41(24):4755-66. PubMed ID: 9822546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1).
    Fryatt T; Pettersson HI; Gardipee WT; Bray KC; Green SJ; Slawin AM; Beall HD; Moody CJ
    Bioorg Med Chem; 2004 Apr; 12(7):1667-87. PubMed ID: 15028260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential.
    Colucci MA; Moody CJ; Couch GD
    Org Biomol Chem; 2008 Feb; 6(4):637-56. PubMed ID: 18264564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.
    Newsome JJ; Swann E; Hassani M; Bray KC; Slawin AM; Beall HD; Moody CJ
    Org Biomol Chem; 2007 May; 5(10):1629-40. PubMed ID: 17571194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines.
    Beall HD; Murphy AM; Siegel D; Hargreaves RH; Butler J; Ross D
    Mol Pharmacol; 1995 Sep; 48(3):499-504. PubMed ID: 7565631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COMPARE analysis of the toxicity of an iminoquinone derivative of the imidazo[5,4-f]benzimidazoles with NAD(P)H:quinone oxidoreductase 1 (NQO1) activity and computational docking of quinones as NQO1 substrates.
    Fagan V; Bonham S; Carty MP; Saenz-Méndez P; Eriksson LA; Aldabbagh F
    Bioorg Med Chem; 2012 May; 20(10):3223-32. PubMed ID: 22522008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benzofuran-, benzothiophene-, indazole- and benzisoxazole-quinones: excellent substrates for NAD(P)H:quinone oxidoreductase 1.
    Newsome JJ; Hassani M; Swann E; Bibby JM; Beall HD; Moody CJ
    Bioorg Med Chem; 2013 Jun; 21(11):2999-3009. PubMed ID: 23635904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolequinone antitumor agents: relationship between quinone structure and rate of metabolism by recombinant human NQO1.
    Beall HD; Hudnott AR; Winski S; Siegel D; Swann E; Ross D; Moody CJ
    Bioorg Med Chem Lett; 1998 Mar; 8(5):545-8. PubMed ID: 9871615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone.
    Shultz CA; Quinn AM; Park JH; Harvey RG; Bolton JL; Maser E; Penning TM
    Chem Res Toxicol; 2011 Dec; 24(12):2153-66. PubMed ID: 21910479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
    Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolequinone antitumor agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase. Part 2.
    Swann E; Barraja P; Oberlander AM; Gardipee WT; Hudnott AR; Beall HD; Moody CJ
    J Med Chem; 2001 Sep; 44(20):3311-9. PubMed ID: 11563930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic properties of NAD(P)H:quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase.
    Wu K; Knox R; Sun XZ; Joseph P; Jaiswal AK; Zhang D; Deng PS; Chen S
    Arch Biochem Biophys; 1997 Nov; 347(2):221-8. PubMed ID: 9367528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction and Scavenging of Chemically Reactive Drug Metabolites by NAD(P)H:Quinone Oxidoreductase 1 and NRH:Quinone Oxidoreductase 2 and Variability in Hepatic Concentrations.
    den Braver-Sewradj SP; den Braver MW; Toorneman RM; van Leeuwen S; Zhang Y; Dekker SJ; Vermeulen NPE; Commandeur JNM; Vos JC
    Chem Res Toxicol; 2018 Feb; 31(2):116-126. PubMed ID: 29281794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
    Mohora M
    Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1).
    Bian J; Xu L; Deng B; Qian X; Fan J; Yang X; Liu F; Xu X; Guo X; Li X; Sun H; You Q; Zhang X
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1244-8. PubMed ID: 25677663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological response of human diploid keratinocytes to quinone-producing compounds: role of NAD(P)H:quinone oxidoreductase 1.
    Foppoli C; De Marco F; Blarzino C; Perluigi M; Cini C; Coccia R
    Int J Biochem Cell Biol; 2005 Apr; 37(4):852-63. PubMed ID: 15694844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid.
    Vredenburg G; Elias NS; Venkataraman H; Hendriks DF; Vermeulen NP; Commandeur JN; Vos JC
    Chem Res Toxicol; 2014 Apr; 27(4):576-86. PubMed ID: 24552538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics.
    Ross D; Siegel D
    Methods Enzymol; 2004; 382():115-44. PubMed ID: 15047100
    [No Abstract]   [Full Text] [Related]  

  • 20. Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups.
    Mendoza MF; Hollabaugh NM; Hettiarachchi SU; McCarley RL
    Biochemistry; 2012 Oct; 51(40):8014-26. PubMed ID: 22989153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.